Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name MGD013
Trade Name
Synonyms MGD-013|Tebotelimab
Drug Descriptions

MGD013 is an engineered antibody protein that targets both PDCD1 (PD-1) and LAG3 resulting in enhanced T-cell mediated anti-tumor immune response (Cancer Res July 15 2016 (76) (14 Supplement) 3217).

DrugClasses Immune Checkpoint Inhibitor 148 LAG3 Antibody 18 PD-L1/PD-1 antibody 117
CAS Registry Number NA
NCIT ID C143957


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Capecitabine + Margetuximab-cmkb + MGD013 + Oxaliplatin Capecitabine MGD013 Margetuximab-cmkb Oxaliplatin 0 1
Fluorouracil + Leucovorin + Margetuximab-cmkb + MGD013 + Oxaliplatin Fluorouracil Leucovorin MGD013 Margetuximab-cmkb Oxaliplatin 0 1
Margetuximab-cmkb + MGD013 MGD013 Margetuximab-cmkb 0 0
MGA271 + MGD013 MGA271 MGD013 0 1
MGD013 MGD013 0 1

Additional content available in CKB BOOST